[1]
N. M. Sydorova and M. Y. Kolesnyk, “Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review)”, Modern Medical Technology, vol. 17, no. 3, pp. 199–204, Sep. 2025.